\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ will\\ most\\ likely\\ receive\\ treatment\\ with\\ a\\ cholinesterase\\ inhibitor\\ \\(eg\\ tacrine\\ or\\ cognex\\)\\ which\\ may\\ delay\\ cognitive\\ decline\\ in\\ the\\ early\\ to\\ mid\\ stages\\ of\\ the\\ disease\\.\ \(0\)\
\-\ pet\\ fluorine\\-18\\ fluorodeoxyglucose\\ scan\\ with\\ high\\ resolution\\ axial\\,\\ sagittal\\,\\ and\\ coronal\\ images\\ demonstrate\\ marked\\ decreased\\ uptake\\ in\\ the\\ posterior\\ parietal\\ and\\ temporal\\ lobes\\ bilaterally\\.\ \(0\)\
\-\ alzheimer\\'s\\ disease\\ based\\ on\\ pet\\ findings\\ and\\ patient\\ history\\.\\ cannot\\ confirm\\ the\\ disease\\ w\\/o\\ brain\\ biopsy\\.\ \(0\)\
\-\ alzheimer\\'s\\ disease\ \(0\)\
\-\ parkinson\\'s\\ disease\\ \\(advanced\\)\ \(0\)\
\-\ fifty\\ seven\\ year\\-old\\ right\\ handed\\ female\\ with\\ worsening\\ dementia\\ versus\\ pseudodementia\\ over\\ approximately\\ two\\ years\\.\ \(0\)\
\-\ although\\ the\\ pet\\ findings\\ are\\ not\\ pathognomic\\ for\\ alzheimer\\'s\\ disease\\,\\ the\\ images\\ are\\ highly\\ predictive\\ of\\ alzheimer\\'s\\ disease\\,\\ particularly\\ with\\ patient\\'s\\ concordant\\ history\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ alzheimer\\:\\ 0\\.2041235418874746\ \(0\)\
\-\ pet\\:\\ 0\\.1019269337200038\ \(0\)\
\-\ \\'s\\:\\ 0\\.0856384826530475\ \(0\)\
\-\ disease\\:\\ 0\\.07406941506446917\ \(0\)\
\-\ cholinesterase\\:\\ 0\\.06678423048459468\ \(0\)\
\-\ tacrine\\:\\ 0\\.06678423048459468\ \(0\)\
\-\ cognex\\:\\ 0\\.06678423048459468\ \(0\)\
\-\ fluorine\\-18\\:\\ 0\\.06678423048459468\ \(0\)\
\-\ pseudodementia\\:\\ 0\\.06678423048459468\ \(0\)\
\-\ pathognomic\\:\\ 0\\.061533115480352674\ \(0\)\
\-\ handed\\:\\ 0\\.05846141011589688\ \(0\)\
\-\ fluorodeoxyglucose\\:\\ 0\\.05459151902676059\ \(0\)\
\-\ parkinson\\:\\ 0\\.05459151902676059\ \(0\)\
\-\ concordant\\:\\ 0\\.05321029511165487\ \(0\)\
\-\ fifty\\:\\ 0\\.05204248693114534\ \(0\)\
\-\ predictive\\:\\ 0\\.04795918010741286\ \(0\)\
\-\ inhibitor\\:\\ 0\\.04626869865806279\ \(0\)\
\-\ decline\\:\\ 0\\.04336724220157714\ \(0\)\
\-\ dementia\\:\\ 0\\.04336724220157714\ \(0\)\
\-\ cognitive\\:\\ 0\\.04303048642452537\ \(0\)\
\-\ seven\\:\\ 0\\.04052865546338463\ \(0\)\
\-\ eg\\:\\ 0\\.03883817401403456\ \(0\)\
\-\ stages\\:\\ 0\\.03883817401403456\ \(0\)\
\-\ receive\\:\\ 0\\.03811612719733513\ \(0\)\
\-\ w\\/o\\:\\ 0\\.03656465437425927\ \(0\)\
\-\ particularly\\:\\ 0\\.0333999937628958\ \(0\)\
\-\ advanced\\:\\ 0\\.03312778157178926\ \(0\)\
\-\ confirm\\:\\ 0\\.03295159322205996\ \(0\)\
\-\ delay\\:\\ 0\\.03212732913229633\ \(0\)\
\-\ highly\\:\\ 0\\.031174530743743045\ \(0\)\
\-\ versus\\:\\ 0\\.03077218358227374\ \(0\)\
\-\ lobes\\:\\ 0\\.0285277455811891\ \(0\)\
\-\ resolution\\:\\ 0\\.027921361432147157\ \(0\)\
\-\ parietal\\:\\ 0\\.027657064015477153\ \(0\)\
\-\ findings\\:\\ 0\\.027558135390756966\ \(0\)\
\-\ mid\\:\\ 0\\.027074025825051938\ \(0\)\
\-\ coronal\\:\\ 0\\.026954720090444827\ \(0\)\
\-\ temporal\\:\\ 0\\.02592341573950104\ \(0\)\
\-\ sagittal\\:\\ 0\\.02582080797353318\ \(0\)\
\-\ uptake\\:\\ 0\\.025719571399198577\ \(0\)\
\-\ worsening\\:\\ 0\\.025488484624248468\ \(0\)\
\-\ marked\\:\\ 0\\.025264238641094748\ \(0\)\
\-\ images\\:\\ 0\\.024837331696202336\ \(0\)\
\-\ based\\:\\ 0\\.024687048198992124\ \(0\)\
\-\ year\\-old\\:\\ 0\\.023778519861350125\ \(0\)\
\-\ early\\:\\ 0\\.023675446739715438\ \(0\)\
\-\ biopsy\\:\\ 0\\.022967373042702733\ \(0\)\
\-\ although\\:\\ 0\\.021863100610428815\ \(0\)\
\-\ bilaterally\\:\\ 0\\.021262918473665935\ \(0\)\
\-\ will\\:\\ 0\\.020253644078629864\ \(0\)\
\-\ approximately\\:\\ 0\\.020028922928451386\ \(0\)\
\-\ brain\\:\\ 0\\.019479935782596682\ \(0\)\
\-\ patient\\:\\ 0\\.01946799842991791\ \(0\)\
\-\ decreased\\:\\ 0\\.01924815456609515\ \(0\)\
\-\ years\\:\\ 0\\.019009417704685474\ \(0\)\
\-\ not\\:\\ 0\\.01870937381427175\ \(0\)\
\-\ two\\:\\ 0\\.01854038816375762\ \(0\)\
\-\ axial\\:\\ 0\\.018475693000514177\ \(0\)\
\-\ likely\\:\\ 0\\.01825977246920952\ \(0\)\
\-\ scan\\:\\ 0\\.018123268639643777\ \(0\)\
\-\ history\\:\\ 0\\.017882038450107326\ \(0\)\
\-\ high\\:\\ 0\\.017716258038460726\ \(0\)\
\-\ are\\:\\ 0\\.01764960412923639\ \(0\)\
\-\ over\\:\\ 0\\.016482140834393658\ \(0\)\
\-\ most\\:\\ 0\\.014945720770667243\ \(0\)\
\-\ posterior\\:\\ 0\\.014921504156836731\ \(0\)\
\-\ demonstrate\\:\\ 0\\.01489736470706849\ \(0\)\
\-\ can\\:\\ 0\\.014683502670220224\ \(0\)\
\-\ may\\:\\ 0\\.014199457340137302\ \(0\)\
\-\ female\\:\\ 0\\.013308789935210862\ \(0\)\
\-\ treatment\\:\\ 0\\.013103158784855205\ \(0\)\
\-\ which\\:\\ 0\\.01208442869123143\ \(0\)\
\-\ \\(\\:\\ 0\\.010944874640058493\ \(0\)\
\-\ \\)\\:\\ 0\\.010811177153231896\ \(0\)\
\-\ \\,\\:\\ 0\\.008203335318705679\ \(0\)\
\-\ or\\:\\ 0\\.00758729355275536\ \(0\)\
\-\ right\\:\\ 0\\.00683054325083649\ \(0\)\
\-\ in\\:\\ 0\\.00638480651727659\ \(0\)\
\-\ the\\:\\ 0\\.0062840583956193545\ \(0\)\
\-\ for\\:\\ 0\\.00552354658062663\ \(0\)\
\-\ on\\:\\ 0\\.005484022820950213\ \(0\)\
\-\ and\\:\\ 0\\.004091113766641329\ \(0\)\
\-\ with\\:\\ 0\\.0035455810936330222\ \(0\)\
\-\ to\\:\\ 0\\.0032353644579014114\ \(0\)\
\-\ a\\:\\ 0\\.003004543953171222\ \(0\)\
\-\ of\\:\\ 0\\.0017652091029998248\ \(0\)\
\-\ \\.\\:\\ 0\\.0016136152771521035\ \(0\)\
